ARCH Venture Partners X, LLC - Oct 27, 2025 Form 4 Insider Report for Neumora Therapeutics, Inc. (NMRA)

Role
10%+ Owner
Signature
ARCH Venture Fund X, L.P. By: ARCH Venture Partners X, L.P., its General Partner By: ARCH Venture Partners X, LLC, its General Partner By: /s/ Mark McDonnell, as Attorney-in-Fact
Stock symbol
NMRA
Transactions as of
Oct 27, 2025
Transactions value $
$4,999,977
Form type
4
Date filed
10/29/2025, 07:19 PM
Previous filing
Aug 1, 2025

Reporting Owners (10)

Name Relationship Address Signature Signature date CIK
ARCH Venture Partners X, LLC 10%+ Owner 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO ARCH Venture Fund X, L.P. By: ARCH Venture Partners X, L.P., its General Partner By: ARCH Venture Partners X, LLC, its General Partner By: /s/ Mark McDonnell, as Attorney-in-Fact 2025-10-29 0001769012
ARCH Venture Fund X, L.P. 10%+ Owner 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO ARCH Venture Fund X Overage, L.P. By: ARCH Venture Partners X Overage, L.P., its General Partner By: ARCH Venture Partners X, LLC, its General Partner By: /s/ Mark McDonnell, as Attorney-in-Fact 2025-10-29 0001757011
ARCH Venture Partners X, L.P. 10%+ Owner 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO ARCH Venture Partners X, L.P. By: ARCH Venture Partners X, LLC, its General Partner By: /s/ Mark McDonnell, as Attorney-in-Fact 2025-10-29 0001782583
ARCH Venture Fund X Overage, L.P. 10%+ Owner 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO ARCH Venture Partners X Overage, L.P. By: ARCH Venture Partners X, LLC, its General Partner By: /s/ Mark McDonnell, as Attorney-in-Fact 2025-10-29 0001757017
ARCH Venture Partners X Overage, L.P. 10%+ Owner 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO ARCH Venture Partners X, LLC By: /s/ Mark McDonnell, as Attorney-in-Fact 2025-10-29 0001768905
ARCH Venture Partners VII, LLC 10%+ Owner 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO ARCH Venture Fund VII, L.P. By: ARCH Venture Partners VII, L.P., its General Partner By: ARCH Venture Partners VII, LLC, its General Partner By: /s/ Mark McDonnell, as Attorney-in-Fact 2025-10-29 0001544443
ARCH Venture Partners VII, L.P. 10%+ Owner 8755 WEST HIGGINS ROAD, SUITE 1025, CHICAGO ARCH Venture Partners VII, L.P. By: ARCH Venture Partners VII, LLC, its General Partner By: /s/ Mark McDonnell, as Attorney-in-Fact 2025-10-29 0001544444
ARCH Venture Fund VII, L.P. 10%+ Owner 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO ARCH Venture Partners VII, LLC By: /s/ Mark McDonnell, as Attorney-in-Fact 2025-10-29 0001402439
ARCH Venture Partners VIII, LLC 10%+ Owner 8755 WEST HIGGINS ROAD, SUITE 1025, CHICAGO ARCH Venture Fund VIII Overage, L.P. By: ARCH Venture Partners VIII, LLC, its General Partner By: /s/ Mark McDonnell, as Attorney-in-Fact 2025-10-29 0001616165
ARCH Venture Fund VIII Overage, L.P. 10%+ Owner 8755 WEST HIGGINS ROAD, SUITE 1025, CHICAGO ARCH Venture Partners VIII, LLC By: /s/ Mark McDonnell, as Attorney-in-Fact 2025-10-29 0001617237

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NMRA Common Stock Purchase $5M +1.92M +46.37% $2.61 6.05M Oct 27, 2025 By ARCH Venture Fund XII, L.P. F1
holding NMRA Common Stock 1.39M Oct 27, 2025 By ARCH Venture Fund VII, L.P. F2
holding NMRA Common Stock 2.32M Oct 27, 2025 By ARCH Venture Fund VIII Overage, L.P. F3
holding NMRA Common Stock 12.2M Oct 27, 2025 By ARCH Venture Fund X, L.P. F4, F6
holding NMRA Common Stock 11.9M Oct 27, 2025 By ARCH Venture Fund X Overage, L.P. F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares held directly by ARCH Venture Fund XII, L.P. (ARCH XII). ARCH Venture Partners XII, L.P. (AVP XII LP) is the general partner of ARCH XII. ARCH Venture Partners XII, LLC (AVP XII LLC) is the general partner of AVP XII LP. Keith Crandell, Kristina Burow, Steven Gillis and Robert Nelsen comprise the investment committee of AVP XII LLC (the AVP XII LLC Committee Members). Each of AVP XII LP and AVP XII LLC may be deemed to beneficially own the shares held by ARCH XII, and each of the AVP XII LLC Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH XII. Each of AVP XII LP, AVP XII LLC and the AVP XII LLC Committee Members disclaims beneficial ownership except to the extent of their pecuniary interest therein, if any.
F2 Represents shares held directly by ARCH Venture Fund VII, L.P. (ARCH VII). ARCH Venture Partners VII, L.P. (AVP VII LP) is the sole general partner of ARCH VII, and ARCH Venture Partners VII, LLC (AVP VII LLC) is the sole general partner of AVP VII LP. Clinton Bybee, Keith Crandell and Robert Nelsen are the managing directors of AVP VII LLC (AVP VII LLC Managing Directors). AVP VII LP and AVP VII LLC may be deemed to beneficially own the shares held by ARCH VII, and each of the AVP VII LLC Managing Directors may be deemed to share the power to direct the disposition and vote of the shares held by ARCH VII. Each of AVP VII LP, AVP VII LLC and the AVP VII LLC Managing Directors disclaims beneficial ownership except to the extent of their pecuniary interest therein, if any.
F3 Represents shares held directly by ARCH Venture Fund VIII Overage, L.P. (ARCH VIII Overage). ARCH Venture Partners VIII, LLC (AVP VIII LLC) is the general partner of ARCH VIII Overage. Clinton Bybee, Keith Crandell and Robert Nelsen are the managing directors of AVP VIII LLC (the AVP VIII LLC Managing Directors). AVP VIII LLC may be deemed to beneficially own the shares held by ARCH VIII Overage, and each of the AVP VIII LLC Managing Directors may be deemed to share the power to direct the disposition and vote of the shares held by ARCH VIII Overage. Each of AVP VIII LLC and the AVP VIII LLC Managing Directors disclaims beneficial ownership except to the extent of their pecuniary interest therein, if any.
F4 Represents shares held directly by ARCH Venture Fund X, L.P. (ARCH X). ARCH Venture Partners X, L.P. (AVP X LP) is the sole general partner of ARCH X.
F5 Represents shares held directly by ARCH Venture Fund X Overage, L.P. (ARCH X Overage). ARCH Venture Partners X Overage, L.P. (AVP X Overage LP) is the sole general partner of ARCH X Overage.
F6 ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of each of AVP X LP and AVP X Overage LP. Keith Crandell, Kristina Burow, Steven Gillis and Robert Nelsen comprise the investment committee of AVP X LLC (the AVP X Committee Members). AVP X LLC may be deemed to beneficially own the shares held by ARCH X and ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X and ARCH X Overage. Each of AVP X LP, AVP X Overage LP, AVP X LLC and the AVP X Committee Members disclaims beneficial ownership of such shares except to the extent of their pecuniary interest therein, if any.

Remarks:

This Form 4 is filed jointly by ARCH X, AVP X LP, ARCH X Overage, AVP X Overage LP, AVP X LLC, ARCH VII, AVP VII LP, AVP VII LLC, ARCH VIII Overage, AVP VIII LLC, ARCH XII, AVP XII LP, AVP XII LLC, Robert Nelsen, Steven Gillis, Keith Crandell, Clinton Bybee (collectively, the "Reporting Persons"). Kristina Burow has direct ownership of Common Stock and is filing her own Form 4 separately.